Lessons of the MMR retraction

Over the last few days I’ve been thinking about the implications of the formal retraction which the Lancet has made of the 1998 paper by Wakefield et al. This, of course, was the notorious study entitled ‘Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.’

The science of the paper has always been noted to have been questionable, given the tiny numbers and study design; it was the press conference to launch the paper which started the media frenzy over MMR and autism. The paper was partially retracted in 2004, by 10 of the 12 authors involved. It is Wakefield’s appearance at the General Medical Council which seems to have spurred the Lancet into making the retraction final.

And yes, it would seem right that the paper is consigned to the dustbin. However, the reality is that there are acres of poor science being published in the medical literature every day. Either we need to get better at pre-publication peer review (various studies suggest we are poor at it) or we need to accept that publication of research is a beginning of a debate, not the end of it. And start retracting more papers earlier rather than later.

Health and science blog




This blog, part of the FT's health series, is a forum for readers interested in the science, policy, management, technology, business and delivery of healthcare.

This blog is no longer active but it remains open as an archive.
Follow on twitter

About our regular bloggers

Margaret McCartney is a Glasgow-based GP and FT Weekend columnist. She started writing for the Life and Arts section in 2005 and moved to the magazine in 2008. She also has her own blog: www.margaretmccartney.com/blog

Clive Cookson has been a science journalist for the whole of his working life. He joined the FT in 1987. Clive, the FT's science editor, picks out the research that everyone should know about. He also discusses key policy issues, from R&D funding to science education.

Andrew Jack is pharmaceuticals correspondent, covering the industry and public health issues. He has been a journalist with the FT for 19 years, based in London, Paris and Moscow

The Health blog: a guide

Comment: To comment, please register with FT.com, which you can do for free here. Please also read our comments policy here.
Contact: You can write to Ursula Milton, the blog's editor, using this email format: firstname.surname@ft.com
Time: UK time is shown on posts.
Follow: Links to the blog's Twitter and RSS feeds are at the top of the page. You can also read the Health blog on your mobile device, by going to www.ft.com/healthblog
FT blogs: See the full range of the FT's blogs here.